Heiner Zimmermann

2PUBLICATIONS
4CO-AUTHORS
Nanotoxicology, health and safetyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 10, 2024
Comparative analysis of tabelecleucel and current treatment in patients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease following hematopoietic cell transplant or solid organ transplant.

Arie Barlev, Heiner Zimmermann, Norma Guzman-Becerra

|May 11, 2021
Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.

Heiner Zimmermann, Mirko Nitsche, Christiane Pott

Pageof 1

Frequent Collaborators

1 joint publications

Arie Barlev

1 joint publications

Aditi Mehta

1 joint publications

Bérengère Macabeo

1 joint publications

M Alan Brookhart